Cuniloside B is primarily studied for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in inhibiting pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory diseases. Preliminary studies suggest it may influence signaling pathways such as NF-κB, which plays a key role in inflammation and cell survival. Due to its natural origin and structural complexity, it is also of interest in the development of novel therapeutic agents derived from plant sources. However, most findings are currently limited to in vitro or animal models, and further research is needed to evaluate its efficacy and safety in clinical applications.